Survival time of mice bearing Ehrlich ascites tumor, with special reference to the effect of hydrocortisone administration.
D000005:Abdomen; D000323:Adrenochrome / Q000494:pharmacology; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D002999:Clone Cells; D004155:Diphenhydramine / Q000494:pharmacology; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006854:Hydrocortisone / Q000627:therapeutic use*; D007621:Karyotyping; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D009368:Neoplasm Transplantation; D009852:Omentum / Q000473:pathology; D010179:Pancreas / Q000473:pathology; D012663:Semicarbazides / Q000494:pharmacology; D013997:Time Factors; D014774:Virulence
D000614:Aminocaproates; D012663:Semicarbazides; D000323:Adrenochrome; D004155:Diphenhydramine; D015122:Mercaptopurine; D006854:Hydrocortisone